Knockout of the muscle-specific E3 ligase MuRF1 affects liver lipid metabolism upon dexamethasone treatment in mice

Archive ouverte

Mosoni, Laurent | Germond, Arno | Coudy-Gandilhon, Cécile | Malige, Mélodie | Claustre, Agnès | Delabrise, Coralie | Djelloul-Mazouz, Mehdi | Delorme, Yoann | Hermet, Julien | Fafournoux, Pierre | Combaret, Lydie | Polge, Cécile | Maurin, Anne-Catherine | Taillandier, Daniel

Edité par CCSD ; ACS Publications -

International audience. In order to preserve muscle mass during catabolic states, investigators are actively searching for a specific inhibitor of MuRF1, the only known E3 ligase able to target muscle contractile proteins for their degradation. However, it is unknown what would be the consequences of such inhibitors on other organs, both in the short and long term. Indeed, skeletal muscles can provide amino acids for liver gluconeogenesis, which is a crucial adaptation for maintaining glucose homeostasis upon elevated energy demands (e.g. during prolonged starvation). Comparing 3-month-old wild-type and MuRF1-KO mice, we measured tissue weights, liver glycogen, lipid and protein content, and liver biochemical composition using Fourier Transform Infrared (FTIR) spectrometry in control animals and in dexamethasone (Dex) treated animals. Dex induces a catabolic situation with muscle atrophy and lipid deposits in the liver. In response to Dex treatment, liver glycogen, lipid and protein content increased in wild type (WT) and MuRF1-KO mice. We found that MuRF1 deletion differentially affected organs weights, the liver of KO mice being hypertrophied upon Dex treatment when compared to WT mice. Upon Dex treatment, muscle mass was preserved in MuRF1-KO mice and, by contrast, liver lipid content increased more in these animals than in WT mice. PLS-DA analysis of FTIR showed that the levels of 13 markers were significantly altered in KO vs. WT mice, witnessing profound alterations of lipid, protein and glycogen content in the liver due to the absence of MuRF1. Using Nile red and oil red O lipid staining, we also found that both membrane-linked lipids and intracellular lipid droplets were altered due to the absence of MuRF1. Altogether, it seems that when the liver is deprived of the possibility to obtain amino acids from muscle upon Dex treatment, there is a concomitant increase in tissue weight and anabolic activity.

Suggestions

Du même auteur

MuRF1 invalidation protects skeletal muscles from atrophy but alters liver metabolism

Archive ouverte | Mosoni, Laurent | CCSD

International audience. A feature of several diseases (cancer, sepsis, heart failure, kidney diseases…) is a catabolic state leading to muscle wasting, and consequently muscle weakness. The main function of skeletal...

Pre-cachectic changes in amino acid homeostasis precede activation of eIF2α signaling in the liver at the onset of C26 cancer-induced cachexia

Archive ouverte | Chaouki, Ghita | CCSD

International audience. The sequence of events associated with cancer cachexia induction needs to be further characterized. Using the C26 mouse model, we found that prior to cachexia, cancer progression was associat...

Induction of ATF4-Regulated Atrogenes Is Uncoupled from Muscle Atrophy during Disuse in Halofuginone-Treated Mice and in Hibernating Brown Bears

Archive ouverte | Cussonneau, Laura | CCSD

International audience. Activating transcription factor 4 (ATF4) is involved in muscle atrophy through the overexpression of some atrogenes. However, it also controls the transcription of genes involved in muscle ho...

Chargement des enrichissements...